Results 61 to 70 of about 2,262,450 (373)

Causes of pleural effusions in horses resident in the UK [PDF]

, 2017
Pleural effusions (PE) reportedly occur most commonly secondary to bacterial pneumonia with neoplastic effusions contributing a minority of cases. The majority of reports originate from the USA and Australia, where long distance transport of horses, a ...
Austin, Collins, DeHeer, Duncanson, Feige, Hepworth-Warren, Lee, Mair, Mair, Norton, Oikawa, Racklyeft, Racklyeft, Raphel, Reuss, Saulez, Smith, Smith, Sweeney, Sweeney, Sweeney, Taintor, Tomlinson   +22 more
core   +1 more source

C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2015
Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different ...
Hala Mohamed Shalaby Samaha, Amany Ragab Elsaid, Rasha Elzehery, Rania Elhelaly   +3 more
doaj   +1 more source

A 22-year-old man with pleural tuberculosis associated hydropneumothorax: Case report and literature review. [PDF]

, 2016
A 22-year-old Asian male presented with fever, non-productive cough, right-sided pleuritic chest pain and was found to have a large right hydropneumothorax. A chest tube was placed. Pleural fluid analysis revealed a lymphocytic predominant exudate and he
Cowan, MD, Scott W., Hehn, Boyd, Manoff, MD, David, Price, MD, Thea, Sharan, Lauren A   +4 more
core   +3 more sources

Positive pressure–assisted pleural aspiration: A case report of a novel procedure and a review of literature

SAGE Open Medical Case Reports, 2022
Drainage of a pleural effusion is done either by inserting an intercostal tube or by aspirating pleural fluid using a syringe. The latter is a time-consuming and labour-intensive procedure.
Pramith Shashinda Ruwanpathirana, Ravini Karunatillake, Saroj Jayasinghe   +2 more
doaj   +1 more source

Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio)

Lung, 2015
AimWe studied the diagnostic potential of serum lactate dehydrogenase (LDH) in malignant pleural effusion.MethodsRetrospective analysis of patients hospitalized with exudative pleural effusion in 2013.ResultsSerum LDH and serum LDH: pleural fluid ADA ...
Akash Verma, J. Abisheganaden, Richard W. Light   +2 more
semanticscholar   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion [PDF]

, 1996
Tumour necrosis factor (TNF) and interleukin-1 (IL-1) are powerful mediators with a key role in inflammation. This study was undertaken to study the presence of TNF and IL-1 in tuberculous effusion where there is marked inflammation and where examination
Christacopoulou, J., Dimakou, K., Gaga, M., Jordanoglou, J., Latsi, P., Orphanidou, D., Pandalos, J., Rasidakis, A., Toumbis, M.   +8 more
core   +1 more source

Pleural fluid tumour markers in malignant pleural effusion with inconclusive cytologic results.

Current Oncology, 2015
BACKGROUND The presence of tumour cells in pleural fluid or tissue defines an effusion as malignant. Cytology analysis of the pleural fluid has about 60% diagnostic sensitivity.
L. Antonangelo, R. Sales, A. Corá, M. Acencio, L. Teixeira, Francisco S. Vargas   +5 more
semanticscholar   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source